User involvement in the design and development of medical devices in epilepsy: A systematic review

IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Epilepsia Open Pub Date : 2024-09-26 DOI:10.1002/epi4.13038
João Ferreira, Ricardo Peixoto, Lígia Lopes, Sándor Beniczky, Philippe Ryvlin, Carlos Conde, João Claro
{"title":"User involvement in the design and development of medical devices in epilepsy: A systematic review","authors":"João Ferreira,&nbsp;Ricardo Peixoto,&nbsp;Lígia Lopes,&nbsp;Sándor Beniczky,&nbsp;Philippe Ryvlin,&nbsp;Carlos Conde,&nbsp;João Claro","doi":"10.1002/epi4.13038","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>This systematic review aims to describe the involvement of persons with epilepsy (PWE), healthcare professionals (HP) and caregivers (CG) in the design and development of medical devices is epilepsy.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A systematic review was conducted, adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Eligibility criteria included peer-reviewed research focusing on medical devices for epilepsy management, involving users (PWE, CG, and HP) during the MDD process. Searches were performed on PubMed, Web of Science, and Scopus, and a total of 55 relevant articles were identified and reviewed.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>From 1999 to 2023, there was a gradual increase in the number of publications related to user involvement in epilepsy medical device development (MDD), highlighting the growing interest in this field. The medical devices involved in these studies encompassed a range of seizure detection tools, healthcare information systems, vagus nerve stimulation (VNS) and electroencephalogram (EEG) technologies reflecting the emphasis on seizure detection, prediction, and prevention. PWE and CG were the primary users involved, underscoring the importance of their perspectives. Surveys, usability testing, interviews, and focus groups were the methods used for capturing user perspectives. User involvement occurs in four out of the five stages of MDD, with production being the exception.</p>\n </section>\n \n <section>\n \n <h3> Significance</h3>\n \n <p>User involvement in the MDD process for epilepsy management is an emerging area of interest holding a significant promise for improving device quality and patient outcomes. This review highlights the need for broader and more effective user involvement, as it currently lags in the development of commercially available medical devices for epilepsy management. Future research should explore the benefits and barriers of user involvement to enhance medical device technologies for epilepsy.</p>\n </section>\n \n <section>\n \n <h3> Plain Language Summary</h3>\n \n <p>This review covers studies that have involved users in the development process of medical devices for epilepsy. The studies reported here have focused on getting input from people with epilepsy, their caregivers, and healthcare providers. These devices include tools for detecting seizures, stimulating nerves, and tracking brain activity. Most user feedback was gathered through surveys, usability tests, interviews, and focus groups. Users were involved in nearly every stage of device development except production. The review highlights that involving users can improve device quality and patient outcomes, but more effective involvement is needed in commercial device development. Future research should focus on the benefits and challenges of user involvement.</p>\n </section>\n </div>","PeriodicalId":12038,"journal":{"name":"Epilepsia Open","volume":"9 6","pages":"2087-2100"},"PeriodicalIF":2.8000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633715/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epilepsia Open","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/epi4.13038","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

This systematic review aims to describe the involvement of persons with epilepsy (PWE), healthcare professionals (HP) and caregivers (CG) in the design and development of medical devices is epilepsy.

Methods

A systematic review was conducted, adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Eligibility criteria included peer-reviewed research focusing on medical devices for epilepsy management, involving users (PWE, CG, and HP) during the MDD process. Searches were performed on PubMed, Web of Science, and Scopus, and a total of 55 relevant articles were identified and reviewed.

Results

From 1999 to 2023, there was a gradual increase in the number of publications related to user involvement in epilepsy medical device development (MDD), highlighting the growing interest in this field. The medical devices involved in these studies encompassed a range of seizure detection tools, healthcare information systems, vagus nerve stimulation (VNS) and electroencephalogram (EEG) technologies reflecting the emphasis on seizure detection, prediction, and prevention. PWE and CG were the primary users involved, underscoring the importance of their perspectives. Surveys, usability testing, interviews, and focus groups were the methods used for capturing user perspectives. User involvement occurs in four out of the five stages of MDD, with production being the exception.

Significance

User involvement in the MDD process for epilepsy management is an emerging area of interest holding a significant promise for improving device quality and patient outcomes. This review highlights the need for broader and more effective user involvement, as it currently lags in the development of commercially available medical devices for epilepsy management. Future research should explore the benefits and barriers of user involvement to enhance medical device technologies for epilepsy.

Plain Language Summary

This review covers studies that have involved users in the development process of medical devices for epilepsy. The studies reported here have focused on getting input from people with epilepsy, their caregivers, and healthcare providers. These devices include tools for detecting seizures, stimulating nerves, and tracking brain activity. Most user feedback was gathered through surveys, usability tests, interviews, and focus groups. Users were involved in nearly every stage of device development except production. The review highlights that involving users can improve device quality and patient outcomes, but more effective involvement is needed in commercial device development. Future research should focus on the benefits and challenges of user involvement.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用户参与癫痫医疗设备的设计和开发:系统综述。
目的本系统综述旨在描述癫痫患者(PWE)、医疗保健专业人员(HP)和护理人员(CG)参与设计和开发癫痫医疗设备的情况:方法:根据《系统综述和元分析首选报告项目》(PRISMA)指南进行了系统综述。资格标准包括同行评议研究,重点关注用于癫痫管理的医疗设备,在 MDD 过程中涉及用户(PWE、CG 和 HP)。在 PubMed、Web of Science 和 Scopus 上进行了检索,共确定并审查了 55 篇相关文章:结果:从 1999 年到 2023 年,与用户参与癫痫医疗设备开发(MDD)相关的论文数量逐渐增加,表明人们对这一领域的兴趣日益浓厚。这些研究涉及的医疗设备包括一系列癫痫发作检测工具、医疗保健信息系统、迷走神经刺激(VNS)和脑电图(EEG)技术,反映了对癫痫发作检测、预测和预防的重视。PWE 和 CG 是所涉及的主要用户,这凸显了他们观点的重要性。调查、可用性测试、访谈和焦点小组是获取用户观点的方法。在 MDD 的五个阶段中,用户参与了其中的四个阶段,但生产阶段除外:重要意义:用户参与癫痫管理的 MDD 过程是一个新兴的关注领域,对提高设备质量和患者疗效具有重大意义。本综述强调了更广泛、更有效的用户参与的必要性,因为目前在用于癫痫管理的商用医疗设备的开发过程中,用户参与还处于滞后状态。未来的研究应探索用户参与的益处和障碍,以提高癫痫医疗设备技术的水平。原文摘要:本综述涵盖了让用户参与癫痫医疗设备开发过程的研究。这里所报告的研究主要是听取癫痫患者、他们的护理人员和医疗保健提供者的意见。这些设备包括检测癫痫发作、刺激神经和跟踪大脑活动的工具。大多数用户反馈都是通过调查、可用性测试、访谈和焦点小组收集的。除生产外,用户几乎参与了设备开发的每个阶段。综述强调,让用户参与可提高设备质量和患者疗效,但在商业设备开发中需要更有效的参与。未来的研究应重点关注用户参与的益处和挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Epilepsia Open
Epilepsia Open Medicine-Neurology (clinical)
CiteScore
4.40
自引率
6.70%
发文量
104
审稿时长
8 weeks
期刊最新文献
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW). Three cases of atypical Rasmussen's encephalitis with delayed-onset seizures. GATAD2B-related developmental and epileptic encephalopathy (DEE): Extending the epilepsy phenotype and a literature appraisal. Intrinsic brain network stability during kainic acid-induced epileptogenesis. Diagnostic yield of utilizing 24-72-hour video electroencephalographic monitoring in the diagnosis of seizures presenting as paroxysmal events in resource-limited settings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1